Park Yong Wook, Kim Yun Hee, Jung Hwan Ui, Jeong Oh Seok, Hong Eun Ji, Kim Hun, Lee Jae Il
Department of Bio R&D, SK Bioscience, Seongnam, Korea.
Department of Veterinary Medicine, College of Veterinary Medicine, Chonnam National University, Gwangju, Korea.
Clin Exp Vaccine Res. 2020 Jan;9(1):56-63. doi: 10.7774/cevr.2020.9.1.56. Epub 2020 Jan 31.
When influenza viruses are cultured in eggs, amino acid mutations of the hemagglutinin may occur through egg adaptation. On the other hand, when influenza viruses are cultured in animal cells, no antigenic mutation occurs unlike in eggs. Therefore, we examined whether the antigenic mutations actually occurred after passage of H3N2 (A/Texas/50/2012) virus up to 15 times in eggs and MDCK-Sky3851 cells.
Prototype A/Texas/50/2012 (H3N2) influenza virus which was isolated from clinical patient, not passaged in egg, was obtained and propagated using the specific pathogen free egg and the MDCK-Sky3851 cell line up to 15 passage, and the changes in the antigen sequence of the influenza viruses were confirmed by gene sequencing and protein structure analysis.
In term of the hemagglutination titer of influenza virus, the reactivity to chicken and guinea pig red blood cell showed different results between egg propagated and cell propagated viruses. In the sequence analysis results for hemagglutinin and neuraminidase, no antigenic mutation was observed throughout all passages when cultured in MDCK-Sky3851 cells. On the other hand, mutations occurred in three amino acid sequences (H156R, G186S, S219F) in hemagglutinin up to 15 passages when cultured in eggs.
H3N2 influenza virus cultured in eggs could lead mutations in amino acid sequence of hemagglutinin, distinct from the corresponding virus cultured in cells for which no antigenic mutation was observed. These findings suggest that cell culture is a more stable and effective way of production with lower risk of antigenic mutations for the manufacture of influenza vaccines.
当流感病毒在鸡胚中培养时,血凝素的氨基酸突变可能会通过鸡胚适应性发生。另一方面,当流感病毒在动物细胞中培养时,与在鸡胚中不同,不会发生抗原性突变。因此,我们研究了H3N2(A/德州/50/2012)病毒在鸡胚和MDCK-Sky3851细胞中传代15次后是否真的发生了抗原性突变。
获得从临床患者分离的、未在鸡胚中传代的A/德州/50/2012(H3N2)流感病毒原型,使用无特定病原体鸡胚和MDCK-Sky3851细胞系传代至15代,并通过基因测序和蛋白质结构分析确认流感病毒抗原序列的变化。
就流感病毒的血凝滴度而言,在鸡胚中传代的病毒和在细胞中传代的病毒对鸡和豚鼠红细胞的反应性显示出不同的结果。在血凝素和神经氨酸酶的序列分析结果中,当在MDCK-Sky3851细胞中培养时,在所有传代过程中均未观察到抗原性突变。另一方面,当在鸡胚中培养时,血凝素中的三个氨基酸序列(H156R、G186S、S219F)在传代15次后发生了突变。
在鸡胚中培养的H3N2流感病毒可导致血凝素氨基酸序列发生突变,这与在细胞中培养的相应病毒不同,后者未观察到抗原性突变。这些发现表明,细胞培养是一种更稳定、有效的生产方式,在生产流感疫苗时发生抗原性突变的风险较低。